ESSA Pharma Inc. announced that it has appointed Mr. Franklin Berger to its board of directors. Mr. Berger's appointment as an independent director is effective immediately. Mr. Berger's background includes strategic advisory work with top-tier venture capital firms and international biopharmaceutical companies.

Mr. Berger currently serves on the board of directors of three public biotechnology companies: Five Prime Therapeutics Inc., Immune Design Corp. and Bellus Health Inc.